293 related articles for article (PubMed ID: 15616311)
1. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.
Deslouches B; Phadke SM; Lazarevic V; Cascio M; Islam K; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2005 Jan; 49(1):316-22. PubMed ID: 15616311
[TBL] [Abstract][Full Text] [Related]
2. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
Deslouches B; Islam K; Craigo JK; Paranjape SM; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2005 Aug; 49(8):3208-16. PubMed ID: 16048927
[TBL] [Abstract][Full Text] [Related]
3. Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.
Deslouches B; Steckbeck JD; Craigo JK; Doi Y; Mietzner TA; Montelaro RC
Antimicrob Agents Chemother; 2013 Jun; 57(6):2511-21. PubMed ID: 23507278
[TBL] [Abstract][Full Text] [Related]
4. De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.
Kang SJ; Won HS; Choi WS; Lee BJ
J Pept Sci; 2009 Sep; 15(9):583-8. PubMed ID: 19544481
[TBL] [Abstract][Full Text] [Related]
5. Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.
Rydberg HA; Carlsson N; Nordén B
Biochem Biophys Res Commun; 2012 Oct; 427(2):261-5. PubMed ID: 22989747
[TBL] [Abstract][Full Text] [Related]
6. Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.
Taira J; Kida Y; Yamaguchi H; Kuwano K; Higashimoto Y; Kodama H
J Pept Sci; 2010 Nov; 16(11):607-12. PubMed ID: 20648478
[TBL] [Abstract][Full Text] [Related]
7. Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility.
Saravanan R; Li X; Lim K; Mohanram H; Peng L; Mishra B; Basu A; Lee JM; Bhattacharjya S; Leong SS
Biotechnol Bioeng; 2014 Jan; 111(1):37-49. PubMed ID: 23860860
[TBL] [Abstract][Full Text] [Related]
8. De novo generation of short antimicrobial peptides with simple amino acid composition.
Lee SH; Kim SJ; Lee YS; Song MD; Kim IH; Won HS
Regul Pept; 2011 Jan; 166(1-3):36-41. PubMed ID: 20736034
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of short arginine- and tryptophan-rich peptides.
Strøm MB; Rekdal O; Svendsen JS
J Pept Sci; 2002 Aug; 8(8):431-7. PubMed ID: 12212806
[TBL] [Abstract][Full Text] [Related]
10. Methods for assessing the structure and function of cationic antimicrobial peptides.
Pate M; Blazyk J
Methods Mol Med; 2008; 142():155-73. PubMed ID: 18437313
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent antimicrobial peptide analogs of Ixosin-B.
Lung FD; Wang KS; Liao ZJ; Hsu SK; Song FY; Liou CC; Wu YS
Bioorg Med Chem Lett; 2012 Jun; 22(12):4185-8. PubMed ID: 22578463
[TBL] [Abstract][Full Text] [Related]
12. Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action.
Shin S; Kim JK; Lee JY; Jung KW; Hwang JS; Lee J; Lee DG; Kim I; Shin SY; Kim Y
J Pept Sci; 2009 Sep; 15(9):559-68. PubMed ID: 19598182
[TBL] [Abstract][Full Text] [Related]
13. Design of Gram-negative selective antimicrobial peptides.
Muhle SA; Tam JP
Biochemistry; 2001 May; 40(19):5777-85. PubMed ID: 11341843
[TBL] [Abstract][Full Text] [Related]
14. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
Conlon JM; Galadari S; Raza H; Condamine E
Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
Wu YS; Liao ZJ; Wang KS; Lung FD
Bioorg Med Chem Lett; 2013 May; 23(10):2929-32. PubMed ID: 23570790
[TBL] [Abstract][Full Text] [Related]
16. Design of imperfectly amphipathic α-helical antimicrobial peptides with enhanced cell selectivity.
Zhu X; Dong N; Wang Z; Ma Z; Zhang L; Ma Q; Shan A
Acta Biomater; 2014 Jan; 10(1):244-57. PubMed ID: 24021230
[TBL] [Abstract][Full Text] [Related]
17. Sequence requirements and an optimization strategy for short antimicrobial peptides.
Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
[TBL] [Abstract][Full Text] [Related]
18. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
Zhu WL; Hahm KS; Shin SY
J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
[TBL] [Abstract][Full Text] [Related]
19. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
Glukhov E; Burrows LL; Deber CM
Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic beta-sheet and alpha-helical potentials.
Jin Y; Hammer J; Pate M; Zhang Y; Zhu F; Zmuda E; Blazyk J
Antimicrob Agents Chemother; 2005 Dec; 49(12):4957-64. PubMed ID: 16304158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
